| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 43.890 | 182.815 | 151.165 | 205.500 | 230.547 | 94.091 | 20.300 |
| Total Income - EUR | - | - | - | 43.890 | 182.815 | 157.117 | 212.663 | 230.547 | 94.092 | 53.982 |
| Total Expenses - EUR | - | - | - | 37.691 | 208.763 | 207.351 | 253.867 | 259.941 | 152.862 | 22.867 |
| Gross Profit/Loss - EUR | - | - | - | 6.199 | -25.948 | -50.234 | -41.204 | -29.394 | -58.770 | 31.116 |
| Net Profit/Loss - EUR | - | - | - | 5.760 | -27.769 | -50.727 | -43.326 | -31.699 | -58.770 | 25.971 |
| Employees | - | - | - | 4 | 9 | 7 | 8 | 8 | 5 | 1 |
Check the financial reports for the company - Bewell Therapies S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 668 | 879 | 5.457 | 5.051 | 4.937 | 496 | 493 |
| Current Assets | - | - | - | 11.824 | 17.310 | 21.809 | 19.645 | 21.061 | 13.392 | 11.712 |
| Inventories | - | - | - | 58 | 1.430 | 0 | 2.037 | 6.191 | 1.210 | 551 |
| Receivables | - | - | - | 609 | 1.299 | 10.410 | 9.708 | 13.011 | 10.746 | 10.224 |
| Cash | - | - | - | 11.158 | 14.581 | 11.399 | 7.899 | 1.858 | 1.437 | 937 |
| Shareholders Funds | - | - | - | 5.803 | -22.135 | -72.443 | -114.162 | -146.216 | -204.543 | -177.428 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 6.690 | 40.323 | 99.709 | 138.858 | 172.163 | 218.380 | 189.633 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 51 | 51 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Bewell Therapies S.r.l.